Neeraj Sood

Names

Identifer

Contact

Affiliations

• University of Southern California / Leonard D. Schaeffer Center for Health Policy and Economics (weight: 99%)
  • EDIRC entry
  • location:
• University of Southern California / Sol Price School of Public Policy (weight: 1%)
  • EDIRC entry
  • location:

Research profile

author of:

• Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? (RePEc:aea:aejpol:v:10:y:2018:i:1:p:113-52)
  by Mariana Carrera & Dana P. Goldman & Geoffrey Joyce & Neeraj Sood
• Who Pays for Obesity? (RePEc:aea:jecper:v:25:y:2011:i:1:p:139-58)
  by Jay Bhattacharya & Neeraj Sood
• Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data (RePEc:bea:papers:0111)
  by John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn
• Productivity Growth in Treating a Major Chronic Health Condition (RePEc:bea:papers:0112)
  by John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn
• Price Regulation in Secondary Insurance Markets (RePEc:bla:jrinsu:v:71:y:2004:i:4:p:643-675)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• The Short and Long Run Effects of Daylight Saving Time on Fatal Automobile Crashes (RePEc:bpj:bejeap:v:7:y:2007:i:1:n:11)
  by Sood Neeraj & Ghosh Arkadipta
• The Effect of State Cost Containment Strategies on the Insurance Status and Use of Antiretroviral Therapy (HAART) for HIV Infected People (RePEc:bpj:fhecpo:v:10:y:2007:i:2:n:3)
  by Ghosh Arkadipta & Sood Neeraj & Leibowitz Arleen
• How Do Consumer-Directed Health Plans Affect Vulnerable Populations? (RePEc:bpj:fhecpo:v:14:y:2011:i:2:n:3)
  by Haviland Amelia M & Sood Neeraj & McDevitt Roland & Marquis M Susan
• The Effects of Consumer-Directed Health Plans on Episodes of Health Care (RePEc:bpj:fhecpo:v:14:y:2011:i:2:n:9)
  by Haviland Amelia M. & Sood Neeraj & McDevitt Roland D. & Marquis M. Susan
• Price Shopping in Consumer-Directed Health Plans (RePEc:bpj:fhecpo:v:16:y:2013:i:1:p:19:n:3)
  by Sood Neeraj & Wagner Zachary & Huckfeldt Peter & Haviland Amelia M.
• Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors (RePEc:bpj:fhecpo:v:16:y:2013:i:1:p:22:n:10)
  by Sood Neeraj & Philipson Tomas J. & Huckfeldt Peter
• The Value of Diagnostic Testing in Personalized Medicine (RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:121-133:n:6)
  by Goldman Dana P. & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Lakdawalla Darius & Agus David & Sood Neeraj & Jena Anupam B. & Philipson Tomas J.
• Wage and Benefit Changes in Response to Rising Health Insurance (RePEc:bpj:fhecpo:v:8:y:2005:n:3)
  by Goldman Dana P & Sood Neeraj & Leibowitz Arleen
• Adverse Selection in Retiree Prescription Drug Plans (RePEc:bpj:fhecpo:v:9:y:2006:i:1:n:4)
  by Goldman Dana P & Joyce Geoffrey & Karaca-Mandic Pinar & Sood Neeraj
• Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems (RePEc:ecl:harjfk:rwp12-007)
  by Huckfeldt, Peter J. & Sood, Neeraj & Escarce, Jose J. & Grabowski, David C. & Newhouse, Joseph P.
• Optimal contributions to flexible spending accounts (RePEc:eee:ecolet:v:76:y:2002:i:1:p:129-135)
  by Bhattacharya, Jayanta & Schoenbaum, Michael & Sood, Neeraj
• Social insurance and the design of innovation incentives (RePEc:eee:ecolet:v:85:y:2004:i:1:p:57-61)
  by Lakdawalla, Darius & Sood, Neeraj
• The reallocation of compensation in response to health insurance premium increases (RePEc:eee:ecolet:v:88:y:2005:i:2:p:147-151)
  by Goldman, Dana P. & Sood, Neeraj & Leibowitz, Arleen
• Evaluation of a COVID-19 rapid antigen testing program among student athletes in a public high school district (RePEc:eee:epplan:v:98:y:2023:i:c:s0149718923000575)
  by Lee, Ryan C. & Sood, Neeraj & Deva, Sohini & Macedo, Marisol & Soto, Daniel W. & Unger, Jennifer B.
• Market evidence of misperceived mortality risk (RePEc:eee:jeborg:v:72:y:2009:i:1:p:451-462)
  by Bhattacharya, Jay & Goldman, Dana & Sood, Neeraj
• The link between public and private insurance and HIV-related mortality (RePEc:eee:jhecon:v:22:y:2003:i:6:p:1105-1122)
  by Bhattacharya, Jayanta & Goldman, Dana & Sood, Neeraj
• Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system (RePEc:eee:jhecon:v:27:y:2008:i:4:p:1046-1059)
  by Sood, Neeraj & Buntin, Melinda Beeuwkes & Escarce, José J.
• The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities (RePEc:eee:jhecon:v:32:y:2013:i:5:p:965-979)
  by Sood, Neeraj & Huckfeldt, Peter J. & Grabowski, David C. & Newhouse, Joseph P. & Escarce, José J.
• Pharmaceutical advertising and Medicare Part D (RePEc:eee:jhecon:v:32:y:2013:i:6:p:1356-1367)
  by Lakdawalla, Darius & Sood, Neeraj & Gu, Qian
• Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems (RePEc:eee:jhecon:v:34:y:2014:i:c:p:1-18)
  by Huckfeldt, Peter J. & Sood, Neeraj & Escarce, José J. & Grabowski, David C. & Newhouse, Joseph P.
• Do “Consumer-Directed” health plans bend the cost curve over time? (RePEc:eee:jhecon:v:46:y:2016:i:c:p:33-51)
  by Haviland, Amelia M. & Eisenberg, Matthew D. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj
• Effects of payment reform in more versus less competitive markets (RePEc:eee:jhecon:v:51:y:2017:i:c:p:66-83)
  by Sood, Neeraj & Alpert, Abby & Barnes, Kayleigh & Huckfeldt, Peter & Escarce, José J.
• Financial risk protection from social health insurance (RePEc:eee:jhecon:v:55:y:2017:i:c:p:14-29)
  by Barnes, Kayleigh & Mukherji, Arnab & Mullen, Patrick & Sood, Neeraj
• The long term effects of “Consumer-Directed” health plans on preventive care use (RePEc:eee:jhecon:v:55:y:2017:i:c:p:61-75)
  by Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj
• Effects of employer-offered high-deductible plans on low-value spending in the privately insured population (RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000096)
  by Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj
• The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data (RePEc:eee:jhecon:v:82:y:2022:i:c:s0167629622000017)
  by Cantor, Jonathan & Sood, Neeraj & Bravata, Dena M. & Pera, Megan & Whaley, Christopher
• Health insurance as a two-part pricing contract (RePEc:eee:pubeco:v:102:y:2013:i:c:p:1-12)
  by Lakdawalla, Darius & Sood, Neeraj
• Prescription drug advertising and drug utilization: The role of Medicare Part D (RePEc:eee:pubeco:v:221:y:2023:i:c:s0047272723000427)
  by Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj
• Innovation and the welfare effects of public drug insurance (RePEc:eee:pubeco:v:93:y:2009:i:3-4:p:541-548)
  by Lakdawalla, Darius & Sood, Neeraj
• Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development (RePEc:eee:pubeco:v:97:y:2013:i:c:p:327-336)
  by Blume-Kohout, Margaret E. & Sood, Neeraj
• HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment (RePEc:eee:socmed:v:111:y:2014:i:c:p:84-93)
  by Delavande, Adeline & Sampaio, Mafalda & Sood, Neeraj
• Government health insurance and spatial peer effects: New evidence from India (RePEc:eee:socmed:v:196:y:2018:i:c:p:131-141)
  by Chatterjee, Chirantan & Joshi, Radhika & Sood, Neeraj & Boregowda, P.
• Health Insurance and the Obesity Externality (RePEc:eme:aheszz:s0731-2199(06)17011-9)
  by Jay Bhattacharya & Neeraj Sood
• Patents, innovation, and the welfare effects of Medicare Part D (RePEc:eme:aheszz:s0731-2199(2010)0000022017)
  by Adam Gailey & Darius Lakdawalla & Neeraj Sood
• Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems (RePEc:hrv:hksfac:8506865)
  by Newhouse, Joseph Paul & Huckfeldt, Peter J & Grabowski, David C. & Sood, Neeraj & Escarce, Jose J
• Do companies in the pharmaceutical supply chain earn excess returns? (RePEc:kap:ijhcfe:v:21:y:2021:i:1:d:10.1007_s10754-020-09291-1)
  by Neeraj Sood & Karen Mulligan & Kimberly Zhong
• Does the market reward quality? Evidence from India (RePEc:kap:ijhcfe:v:23:y:2023:i:3:d:10.1007_s10754-022-09341-w)
  by Zachary Wagner & Somalee Banerjee & Manoj Mohanan & Neeraj Sood
• New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity (RePEc:kap:ijhcfe:v:4:y:2004:i:3:p:231-246)
  by Bernard Friedman & Neeraj Sood & Kelly Engstrom & Diane McKenzie
• Market power and state costs of HIV/AIDS drugs (RePEc:kap:ijhcfe:v:7:y:2007:i:1:p:59-71)
  by Arleen Leibowitz & Neeraj Sood
• The effect of federal research funding on formation of university-firm biopharmaceutical alliances (RePEc:kap:jtecht:v:40:y:2015:i:5:p:859-876)
  by Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood
• Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data (RePEc:lvl:lacicr:1038)
  by Pierre-Carl Michaud & Darius Lakdawalla & Dana Goldman & Neeraj Sood & Ze Cong
• Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries (RePEc:mpr:mprres:88ac266a27d2497c84f0a2db7fa65fe7)
  by Neeraj Sood & Arkadipta Ghosh & José J. Escarce
• Does Health Insurance Make You Fat? (RePEc:nbr:nberch:11825)
  by Jay Bhattacharya & M. Kate Bundorf & Noemi Pace & Neeraj Sood
• Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data (RePEc:nbr:nberch:14275)
  by John A. Romley & Abe Dunn & Dana Goldman & Neeraj Sood
• Wage and Benefit Changes in Response to Rising Health Insurance (RePEc:nbr:nberch:9875)
  by Dana P. Goldman & Neeraj Sood & Arleen Leibowitz
• Adverse Selection in Retiree Prescription Drug Plans (RePEc:nbr:nberch:9881)
  by Dana P. Goldman & Geoffrey Joyce & Pinar Karaca-Mandic & Neeraj Sood
• HIV Breakthroughs and Risk Sexual Behavior (RePEc:nbr:nberwo:10516)
  by Dana Goldman & Darius Lakdawalla & Neeraj Sood
• Wage and Benefit Changes in Response to Rising Health Insurance Costs (RePEc:nbr:nberwo:11063)
  by Dana Goldman & Neeraj Sood & Arleen Leibowitz
• Technology, Monopoly, and the Decline of the Viatical Settlements Industry (RePEc:nbr:nberwo:11164)
  by Neeraj Sood & Abby Alpert & Jay Bhattacharya
• Health Insurance and the Obesity Externality (RePEc:nbr:nberwo:11529)
  by Jay Bhattacharya & Neeraj Sood
• Insurance and Innovation in Health Care Markets (RePEc:nbr:nberwo:11602)
  by Darius Lakdawalla & Neeraj Sood
• Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System (RePEc:nbr:nberwo:12556)
  by Neeraj Sood & Melinda Beeuwkes Buntin & Jose J. Escarce
• Health Insurance as a Two-Part Pricing Contract (RePEc:nbr:nberwo:12681)
  by Darius Lakdawalla & Neeraj Sood
• Criminal Prosecution and HIV-related Risky Behavior (RePEc:nbr:nberwo:12903)
  by Adeline Delavande & Dana Goldman & Neeraj Sood
• The Welfare Effects of Public Drug Insurance (RePEc:nbr:nberwo:13501)
  by Darius Lakdawalla & Neeraj Sood
• Mortality Risks, Health Endowments, and Parental Investments in Infancy: Evidence from Rural India (RePEc:nbr:nberwo:13649)
  by Ashlesha Datar & Arkadipta Ghosh & Neeraj Sood
• The Impact of Medicare Part D on Pharmaceutical R&D (RePEc:nbr:nberwo:13857)
  by Margaret E. Blume-Kohout & Neeraj Sood
• Federal Life Sciences Funding and University R&D (RePEc:nbr:nberwo:15146)
  by Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood
• Does Health Insurance Make You Fat? (RePEc:nbr:nberwo:15163)
  by Jay Bhattacharya & Kate Bundorf & Noemi Pace & Neeraj Sood
• The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities (RePEc:nbr:nberwo:17125)
  by Neeraj Sood & Peter J. Huckfeldt & David C. Grabowski & Joseph P. Newhouse & José J. Escarce
• Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems (RePEc:nbr:nberwo:17870)
  by Peter J. Huckfeldt & Neeraj Sood & José J. Escarce & David C. Grabowski & Joseph P. Newhouse
• The Impact of Insurance and HIV Treatment Technology on HIV Testing (RePEc:nbr:nberwo:19397)
  by Neeraj Sood & Yanyu Wu
• Identifying the Health Production Function: The Case of Hospitals (RePEc:nbr:nberwo:19490)
  by John A. Romley & Neeraj Sood
• Conforming and Non-conforming Peer Effects in Vaccination Decisions (RePEc:nbr:nberwo:19528)
  by Elizabeth Bodine-Baron & Sarah Nowak & Raffaello Varadavas & Neeraj Sood
• Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals (RePEc:nbr:nberwo:20927)
  by Peter J. Huckfeldt & Amelia Haviland & Ateev Mehrotra & Zachary Wagner & Neeraj Sood
• Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time? (RePEc:nbr:nberwo:21031)
  by Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood
• Effects of Payment Reform in More versus Less Competitive Markets (RePEc:nbr:nberwo:21654)
  by Neeraj Sood & Abby Alpert & Kayleigh Barnes & Peter Huckfeldt & Jose Escarce
• Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D (RePEc:nbr:nberwo:21714)
  by Abby Alpert & Darius Lakdawalla & Neeraj Sood
• Financial Risk Protection from Social Health Insurance (RePEc:nbr:nberwo:22620)
  by Kayleigh Barnes & Arnab Mukherji & Patrick Mullen & Neeraj Sood
• Does The Market Reward Quality?: Evidence from India (RePEc:nbr:nberwo:26460)
  by Zachary Wagner & Somalee Banerjee & Manoj Mohanan & Neeraj Sood
• The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data (RePEc:nbr:nberwo:28131)
  by Jonathan H. Cantor & Neeraj Sood & Dena Bravata & Megan Pera & Christopher M. Whaley
• Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission (RePEc:nbr:nberwo:28645)
  by Dena Bravata & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley
• The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality (RePEc:nbr:nberwo:28930)
  by Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley
• The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes (RePEc:nbr:nberwo:29593)
  by Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley
• The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines (RePEc:nbr:nberwo:30602)
  by Virat Agrawal & Neeraj Sood & Christopher M. Whaley
• The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization (RePEc:nbr:nberwo:30791)
  by Matthew D. Eisenberg & Brendan Rabideau & Abby E. Alpert & Rosemary J. Avery & Jeff Niederdeppe & Neeraj Sood
• Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative (RePEc:nbr:nberwo:31139)
  by Jagpreet Chhatwal & Alec Aaron & Huaiyang Zhong & Neeraj Sood & Risha Irvin & Harvey J. Alter & Yueran Zhuo & Joshua M. Sharfstein & John W. Ward
• Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market (RePEc:nbr:nberwo:31536)
  by Charles Gray & Abby E. Alpert & Neeraj Sood
• The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality (RePEc:nbr:nberwo:31812)
  by Virat Agrawal & Neeraj Sood & Christopher M. Whaley
• The Link Between Public and Private Insurance and HIV-Related Mortality (RePEc:nbr:nberwo:9346)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• The Reallocation of Compensation in Response to Health Insurance Premium Increases (RePEc:nbr:nberwo:9540)
  by Dana P. Goldman & Neeraj Sood & Arleen Leibowitz
• Market Evidence of Misperceived Prices and Mistaken Mortality Risks (RePEc:nbr:nberwo:9863)
  by Jay Bhattacharya & Dana Goldman & Neeraj Sood
• HIV Breakthroughs and Risky Sexual Behavior (RePEc:oup:qjecon:v:121:y:2006:i:3:p:1063-1102.)
  by Darius Lakdawalla & Neeraj Sood & Dana Goldman
• University R&D Funding Strategies in a Changing Federal Funding Environment (RePEc:oup:scippl:v:42:y:2015:i:3:p:355-368.)
  by Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood
• Private Sector Participation and Health System Performance in Sub-Saharan Africa (RePEc:plo:pone00:0013243)
  by Joanne Yoong & Nicholas Burger & Connor Spreng & Neeraj Sood
• Do People Taking Flu Vaccines Need Them the Most? (RePEc:plo:pone00:0026347)
  by Qian Gu & Neeraj Sood
• Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya (RePEc:plo:pone00:0027194)
  by Neeraj Sood & Nicholas Burger & Joanne Yoong & Dan Kopf & Connor Spreng
• Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya (RePEc:plo:pone00:0027885)
  by Nicholas E Burger & Daniel Kopf & Connor P Spreng & Joanne Yoong & Neeraj Sood
• National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates (RePEc:plo:pone00:0166858)
  by John Romley & Prodyumna Goutam & Neeraj Sood
• Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions (RePEc:plo:pone00:0215876)
  by Jing Gu & Neeraj Sood & Abe Dunn & John Romley
• Luck of the draw: Role of chance in the assignment of medicare readmissions penalties (RePEc:plo:pone00:0261363)
  by Andrew D Wilcock & Sushant Joshi & José Escarce & Peter J Huckfeldt & Teryl Nuckols & Ioana Popescu & Neeraj Sood
• Do Statins Reduce the Health and Health Care Costs of Obesity? (RePEc:spr:pharme:v:33:y:2015:i:7:p:723-734)
  by Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood
• The Impact of Insurance on HIV Testing (RePEc:tpr:amjhec:v:1:y:2015:i:4:p:515-536)
  by Neeraj Sood & Zachary Wagner & Yanyu Wu
• The Impact of Insurance on HIV Testing (RePEc:ucp:amjhec:v:1:y:2015:i:4:p:515-536)
  by Neeraj Sood & Zachary Wagner & Yanyu Wu
• Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior (RePEc:ucp:jlawec:doi:10.1086/655806)
  by Adeline Delavande & Dana Goldman & Neeraj Sood
• The impact of COVID‐19 shelter‐in‐place policy responses on excess mortality (RePEc:wly:hlthec:v:32:y:2023:i:11:p:2499-2515)
  by Virat Agrawal & Jonathan Cantor & Neeraj Sood & Christopher Whaley
• Why Medicare Price Negotiation Is The Wrong Prescription For Rising Drug Spending (RePEc:wly:jpamgt:v:35:y:2016:i:4:p:956-963)
  by Geoffrey F. Joyce & Neeraj Sood
• Why Medicare Price Negotiation Is The Wrong Prescription For Rising Drug Spending: Response To Rena Conti (RePEc:wly:jpamgt:v:35:y:2016:i:4:p:970-972)
  by Geoffrey F. Joyce & Neeraj Sood